Community Search
WPC Scientific Update: Parkinson Pipeline Umbrella
Share |

 

 

All six sessions presented from September 30 - October 2, 2014



SESSION I (Click here to view archived session)

Alpha-synuclein, Neuron Killer or Tombstone?


Learning Objective: To discuss the notion of protein folding and its role in pathological situations

Discussant: Marie-Francoise Chesselet (USA)
Speakers:   Michael Schlossmacher (Canada)
                   Leonidas Stefanis (Greece) 
                   Jeffrey Kordower (USA)

 

Download Session I Summary

Download key points from Session I


SESSION II (Click here to view archived session)

Averting an Energy Crisis: the Vital Role of Mitochondria in PD


Learning Objective: To explain mitochondrial biology and questions surrounding possible mitochondrial defect in PD

Discussant: Serge Przedborski (USA)
Speakers:   Miquel Vila (Spain)
                   Charleen Chu (USA)
                   Eric Schon (USA)

 

Download Session II Summary

Download key points from Session II

 

SESSION III (Click here to view archived session)

Therapeutics & Delivery Systems

Learning Objective: To understand and explain recent developments in the field of oral and non-oral drug delivery

Discussant: Jon Palfreman (USA)
Speakers:    Peter LeWitt (USA)
                    Walter Maetzler (Germany)
                    Etienne Hirsch (France)

 

Download Session III Summary

Download key points from Session III


SESSION IV (Click here to view archived session)

Unblocking the Treatment Pipeline


Learning Objective: To be able to identify three challenges to the treatment pipeline for new Parkinson's medications

Discussant: David Iverson (USA)
Speakers:   Michael Schwarzschild (USA) [SURE-PD 2014 study]
                   Charles Adler (USA) [Low clinical diagnostic accuracy of early vs advanced Parkinson disease]
                   Christopher Goetz (USA)

 

Download Session IV Summary

Download key points from Session IV

 

SESSION V (Click here to view archived session)

The Limits of Dopaminergic Disease Modifying Strategies in a Non-motor Symptom World

Learning Objective: To identify and explain two non-motor symptoms of Parkinson's that dopamine treatments have limited ability to alter

Discussant: Patrik Brundin (USA)
Speakers:   Oscar Gershanik (Argentina)
                   Ray Chaudhuri (UK)
                   David Burn (UK)


Download Session V Summary

Download key points from Session V

SESSION VI (Click here to view archived session)

Personalized Medicine


Learning Objective: To discuss and explain the role of personalized medicine in Parkinson's disease and identify how researchers feel personalized medicine will change the lives of people living with PD

Discussant: Bastiaan Bloem (Netherlands)
Speakers:   Ronald Pfeiffer (USA)
                   Jon Stoessl (Canada)
                   Roger Barker (UK)

 

Download Session VI Summary

Download key points from Session VI



General Information

 

Program (Archived sessions available for viewing)

Faculty

Continuing Education 

Registration


Membership Management Software Powered by YourMembership.com®  ::  Legal